12 results found.

Alcoholism, Alcohol Abuse, Smoking, or Alcohol Drinking Clinical Trial using Varenicline

Yale University - Recruiting 18 years to 70 years.
- 1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers.
Varenicline

Polymorphism-Genetic, Alcohol Drinking, Alcohol-Related Disorders Clinical Trial using OPRM1 AA118; Morphine; Placebo; OPRM1 GX118

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 55 years.
- OPRM1 A118G SNP Effect on Striatal Dopamine Response to an IV Opiate.
OPRM1 AA118; Morphine; Placebo; OPRM1 GX118

Alcoholism, Alcohol Dependence, Alcohol Drinking Related Problems Clinical Trial using Baclofen

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics.
Baclofen

Alcohol Abuse Clinical Trial using Standard Care; Multidimensional Family Therapy; Family Motivational Interviewing Intervention

University of Miami - Recruiting 12 years to 18 years.
- Family Intervention for Teen Drinking and Alcohol-Related Crises in the ER.
Standard Care; Multidimensional Family Therapy; Family Motivational Interviewing Intervention

Alcohol Dependence Clinical Trial using Naltrexone; Control

Centre for Addiction and Mental Health - Recruiting 18 years to 65 years.
- A Multi-site Study to Disseminate and Evaluate Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers.
Naltrexone; Control

Alcoholism, Alcohol-Related Disorders, Alcohol Dependence, Alcoho Clinical Trial using PF-05190457

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- A Novel Compound for Alcoholism Treatment: A Translational Strategy.
PF-05190457

Alcohol Dependence, Alcohol Drinking, Stress, or Alcohol-Related Clinical Trial using Pioglitazone; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 21 years to 65 years.
- Role of Proinflammatory Signaling in Alcohol Craving.
Pioglitazone; Placebo

Alcoholism, Alcohol Dependence, or Alcohol Drinking Related Probl Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- Assessment and Treatment of People With Alcohol Drinking Problems.

Alcohol Drinking Clinical Trial using Naltrexone

Yale University - Recruiting 21 years to 50 years.
- Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors.
Naltrexone

Hazardous Alcohol Use, Binge Drinking, High Risk Sexual Behaviors Clinical Trial using Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

Johns Hopkins University - Recruiting 18 years or older.
- Computerized BI for Binge Drinking HIV At-Risk and Infected African-American Women.
Computerized brief alcohol intervention with IVR booster calls; Computer delivered brief alcohol intervention; Attention Control

Alcohol Consumption Clinical Trial using Kudzu; Placebo

Mclean Hospital - Recruiting 21 years to 40 years.
- Isoflavone (Kudzu) Extract Effects on Alcohol Drinking: Single Dose Pretreatment Study.
Kudzu; Placebo

At-risk Drinking, or Type 2 Diabetes Clinical Trial using Brief alcohol intervention; General health education

Rhode Island Hospital - Recruiting 18 years or older.
- Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics.
Brief alcohol intervention; General health education